The Cost of COPD patients inside and outside Hospital (comparative study )
Dr Marwa Sayed Daif; Haytham Samy Diab; Adell Khattab, Samar El Sharkaw;
Abstract
Chronic obstructive pulmonary disease (COPD) is a highly prevalent and debilitating disease that has a significant impact on patient quality of life and the costs borne by the health care system. An exacerbation of COPD is the most common condition that requires hospital admission, and contributes substantially to the related economic impact. Therefore, COPD exacerbations have been considered the most important target for reducing costs.
A study in the UK National Health Service (NHS) in 2001 showed that the total excess primary care cost associated with acute exacerbations of chronic bronchitis in the COPD-diagnosed population was £35.7 million.
This included the excess cost of all prescription medications, general practitioner (GP).
(Nurmatov et al., 2012)
The aim of this study was to compare the Cost of COPD exacerbations managed in Hospital as regard (Hospital stay, Antibiotic, Chest Medication, Medications of Co-morbid diseases) with COPD managed in Outpatient Clinic.
The present study was conducted on (74) male patients divided to 3 groups:
Group A: consist of COPD patients with acute exacerbation managed in Chest department.
Group B: consist of COPD patients with acute exacerbation managed in Respiratory ICU and received mechanical ventilation.
Group C: consist of COPD patients with acute exacerbation managed in Respiratory ICU without mechanical ventilation.
All patients were followed after discharge as regard The Cost of their medications.
The results obtained were collected, tabulated and submitted for statistical analysis.
From the present study the following results were obtained:
1. There is significant statistical difference between total cost of medications of COPD patients without co morbid diseases, and total cost of medications of COPD patients with Co morbid diseases.
2. There is highly significant statistical difference as regard Total Cost of medications of COPD patients treated in chest department versus patients treated Respiratory ICU (either mechanically ventilated or not).
3. The Cost of Antibiotic increased proportionately with the increase of severity of COPD patient, as the main cost of patients treated in chest department was L.E 1259.7± SD E.L 1256.2) and the main cost of patients treated in Respiratory ICU (mechanically ventilated) was L.E 4970.7 ± SD L.E 3807.4, the main cost of patients treated in respiratory ICU (not mechanically ventilated ) was L.E 2627.8 ±1777.3.
4. There is highly significant statistical difference between studied groups as regard duration of Hospitalization and frequency of Hospitalization with mean duration of Hospitalization in chest department was 12.2±5.6 days and its frequency was 1.9±1.3, mean duration of Hospitalization in ICU (mechanically ventilated patient ) was 28.1± 15.9 days and its frequency was 3.1± 1.7, and mean duration of Hospitalization in ICU ( not mechanically ventilated patient ) was 22 ± 12.2 days and its frequency was 2.7±1.
A study in the UK National Health Service (NHS) in 2001 showed that the total excess primary care cost associated with acute exacerbations of chronic bronchitis in the COPD-diagnosed population was £35.7 million.
This included the excess cost of all prescription medications, general practitioner (GP).
(Nurmatov et al., 2012)
The aim of this study was to compare the Cost of COPD exacerbations managed in Hospital as regard (Hospital stay, Antibiotic, Chest Medication, Medications of Co-morbid diseases) with COPD managed in Outpatient Clinic.
The present study was conducted on (74) male patients divided to 3 groups:
Group A: consist of COPD patients with acute exacerbation managed in Chest department.
Group B: consist of COPD patients with acute exacerbation managed in Respiratory ICU and received mechanical ventilation.
Group C: consist of COPD patients with acute exacerbation managed in Respiratory ICU without mechanical ventilation.
All patients were followed after discharge as regard The Cost of their medications.
The results obtained were collected, tabulated and submitted for statistical analysis.
From the present study the following results were obtained:
1. There is significant statistical difference between total cost of medications of COPD patients without co morbid diseases, and total cost of medications of COPD patients with Co morbid diseases.
2. There is highly significant statistical difference as regard Total Cost of medications of COPD patients treated in chest department versus patients treated Respiratory ICU (either mechanically ventilated or not).
3. The Cost of Antibiotic increased proportionately with the increase of severity of COPD patient, as the main cost of patients treated in chest department was L.E 1259.7± SD E.L 1256.2) and the main cost of patients treated in Respiratory ICU (mechanically ventilated) was L.E 4970.7 ± SD L.E 3807.4, the main cost of patients treated in respiratory ICU (not mechanically ventilated ) was L.E 2627.8 ±1777.3.
4. There is highly significant statistical difference between studied groups as regard duration of Hospitalization and frequency of Hospitalization with mean duration of Hospitalization in chest department was 12.2±5.6 days and its frequency was 1.9±1.3, mean duration of Hospitalization in ICU (mechanically ventilated patient ) was 28.1± 15.9 days and its frequency was 3.1± 1.7, and mean duration of Hospitalization in ICU ( not mechanically ventilated patient ) was 22 ± 12.2 days and its frequency was 2.7±1.
Other data
| Title | The Cost of COPD patients inside and outside Hospital (comparative study ) | Authors | Dr Marwa Sayed Daif ; Haytham Samy Diab; Adell Khattab, Samar El Sharkaw | Keywords | COPD,Cost,Burden | Issue Date | 15-Sep-2015 | Publisher | Marwa Sayed Daif |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.